A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
Public ClinicalTrials.gov record NCT02718300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of parsaclisib and ruxolitinib in subjects with myelofibrosis.
Study identification
- NCT ID
- NCT02718300
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 8, 2017 (Actual)
- Primary completion
- Jan 28, 2021 (Actual)
- Completion
- Apr 29, 2022 (Actual)
- Last update posted
- May 1, 2024
2017 – 2022
United States locations
- U.S. sites
- 39
- U.S. states
- 23
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology & Oncolgy Associates Llc | Birmingham | Alabama | 35223 | — |
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Alta Bates Medical Center | Berkeley | California | 94704 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| California Cancer Associates For Research and Excellence | Fresno | California | 93720 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| UCLA School of Medicine | Los Angeles | California | 90095 | — |
| Pcr Oncology | Pismo Beach | California | 93449 | — |
| California Cancer Assoc. for Research and Excellence | San Marcos | California | 92069 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Shands Hospital | Gainesville | Florida | 32610 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Indiana Blood and Marrow Transplantation | Indianapolis | Indiana | 46237 | — |
| McFarland Clinic | Ames | Iowa | 50010 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| Saint Agnes Hospital | Baltimore | Maryland | 21229 | — |
| Cancer Center For Blood Disorders | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Washington University School of Medicine | St Louis | Missouri | 63130 | — |
| Summit Medical Group | Florham Park | New Jersey | 07932 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| New Mexico Cancer Care Alliance | Albuquerque | New Mexico | 87106 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Oncology Hematology Care, Inc. | Cincinnati | Ohio | 45230 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Rush University Medical Center | Nashville | Tennessee | 37203 | — |
| Baylor Scott and White Research Institute | Dallas | Texas | 75246 | — |
| Md Anderson Cancer Center | Houston | Texas | 77030 | — |
| Cancer Care Centers of South Texas | San Antonio | Texas | 78217 | — |
| Renovatio Clinical Consultants Llc | The Woodlands | Texas | 77380 | — |
| Va Salt Lake City Health Care System | Salt Lake City | Utah | 84112 | — |
| Vista Oncology Inc Ps | Olympia | Washington | 98506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02718300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2024 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02718300 live on ClinicalTrials.gov.